coronary stent
Showing 1 - 25 of >10,000
Coronary Stenosis, Coronary Artery Disease Trial (IoNIR Ridaforolimus-Eluting Coronary Stent System)
Not yet recruiting
- Coronary Stenosis
- Coronary Artery Disease
- IoNIR Ridaforolimus-Eluting Coronary Stent System
- (no location specified)
Oct 1, 2023
Drug-eluting Stent, Coronary Artery Disease Trial in Suwon (Genoss® DES system, Genoss® Osfit system)
Recruiting
- Drug-eluting Stent
- Coronary Artery Disease
- Genoss® DES system, Genoss® Osfit system
-
Suwon, Korea, Republic ofAjou University Hospital
Sep 27, 2023
Coroflex® ISAR NEO PMCF Study y ( rEPIC07 )
Not yet recruiting
- Coronary Artery Disease (CAD)
- Ischemic Heart Disease
- Coroflex® ISAR NEO coronary stent system
- (no location specified)
Jan 16, 2023
Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases Trial in Shenyang, Beijing (Resolute Onyx™
Active, not recruiting
- Ischemic Heart Disease
- +4 more
- Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
- Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System
-
Shenyang, Liaoning, China
- +1 more
Nov 2, 2022
BIOFLOW-china Post-marketing Study (BIOTRONIK)
Not yet recruiting
- In-Stent Stenosis (Restenosis) of Coronary Artery Stent
- Native Coronary Artery Stenosis
- BIOTRONIK Orsiro Sirolimus-Eluting Coronary Stent System
-
Harbin, Heilongjiang, ChinaThe Fourth Affiliated Hospital of Harbin Medical University
Dec 26, 2022
Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease Trial (Ultimaster Nagomi™)
Not yet recruiting
- Cardiovascular Disease
- +2 more
- Ultimaster Nagomi™
- (no location specified)
Jan 20, 2023
Heart Attack Trial in Rochester (PEP in Acute Myocardial Infarction)
Enrolling by invitation
- Percutaneous Coronary Intervention
-
Rochester, MinnesotaMayo Clinic
Jan 30, 2023
Coronary Heart Disease, Drug Eluting Stent Trial (Absorbable zinc alloy drug eluting coronary stent system)
Not yet recruiting
- Coronary Heart Disease
- Drug Eluting Stent
- Absorbable zinc alloy drug eluting coronary stent system
- (no location specified)
Jul 26, 2022
A U.S Post Approval Study Evaluating SYNERGY XLV Stent System
Active, not recruiting
- Atherosclerosis
- +3 more
- SYNERGY XLV (Megatron) Coronary Stent System
-
New Haven, Connecticut
- +7 more
Jan 20, 2023
In-stent Restenosis Trial (Drug-eluting Coronary Spur Stent System)
Not yet recruiting
- In-stent Restenosis
- Drug-eluting Coronary Spur Stent System
- (no location specified)
Oct 31, 2023
Coronary Stenosis, Coronary Disease, Non-ST Elevated Myocardial Infarction Trial (IoNIR Ridaforolimus-Eluting Coronary Stent
Not yet recruiting
- Coronary Stenosis
- +3 more
- IoNIR Ridaforolimus-Eluting Coronary Stent System
- (no location specified)
May 3, 2022
Coronary Artery Disease, Drug-eluting Stents Trial in Yongin (ultimaster)
Recruiting
- Coronary Artery Disease
- Drug-eluting Stents
- ultimaster
-
Yongin, Gyeonggi-do, Korea, Republic ofYongin Severance Hospital
Dec 22, 2022
Coronary Stent Restenosis Trial in Szeged, Budapest (Intravascular management of prior implanted coronary drug eluting stent
Recruiting
- Coronary Stent Restenosis
- Intravascular management of prior implanted coronary drug eluting stent restenosis
-
Szeged, Csongád-Csanád, Hungary
- +1 more
Jun 27, 2022
Stent-balloon-stent Technique in Treatment of Coronary
Recruiting
- Coronary Disease
- +4 more
- Stent-balloon-stent (SBS) technique
-
Zhengzhou, Henan, ChinaFuwai Central China Cardiovascular Hospital
Sep 13, 2023
Coronary Artery Disease Trial (MeRes 100 Sirolimus-eluting Bioresorbable Vascular Scaffold System (BRS))
Not yet recruiting
- Coronary Artery Disease
- MeRes 100 Sirolimus-eluting Bioresorbable Vascular Scaffold System (BRS)
- (no location specified)
Jun 10, 2022
Percutaneous Coronary Intervention (PCI), Coronary Artery Disease (CAD), De Novo Stenosis Trial in Tunis (DEB for de Novo
Recruiting
- Percutaneous Coronary Intervention (PCI)
- +2 more
- DEB for de Novo Lesions
- DES for de Novo Lesions
-
Tunis, TunisiaMilitary hospital of Tunis
Aug 23, 2022
Coronary Artery Disease, High Bleeding Risk Patients Trial (BioFreedom Ultra)
Not yet recruiting
- Coronary Artery Disease
- High Bleeding Risk Patients
- BioFreedom Ultra
- (no location specified)
Dec 7, 2022
Ischemic Heart Disease Trial in Seoul (Implanatation of Genoss DES sirolimus-eluting coronary system, Implanatation of Xience
Recruiting
- Ischemic Heart Disease
- Implanatation of Genoss DES sirolimus-eluting coronary system
- Implanatation of Xience DES everolimus-eluting coronary system
-
Seoul, Korea, Republic ofCardiac and Vascular Center; Samsung Medical Center
Jun 29, 2022
Coronary Artery Disease Trial in Porto Alegre (implant)
Active, not recruiting
- Coronary Artery Disease
- implant
-
Porto Alegre, Rio Grande Do Sul, BrazilUnião Brasileira de Educação e Assistência - Hospital São Lucas
May 7, 2022
BIONICS - Pharmacokinetics (PK) Trial
Completed
- Heart Disease
- BioNIR Ridaforolimus Eluting Coronary Stent
-
Scottsdale, Arizona
- +1 more
Apr 5, 2022
Coronary Artery Disease, Ischemic Heart Disease Trial in Suwon (Procedure: planed 2-stent strategy, Procedure: provisional
Recruiting
- Coronary Artery Disease
- Ischemic Heart Disease
- Procedure: planed 2-stent strategy
- Procedure: provisional 1-stent plus DEB strategy
-
Suwon, Gyeonggi-do, Korea, Republic ofSt. Vincent's Hospital , the Catholic University
Aug 17, 2023
EluNIR Ridaforolimus Eluting Coronary Stent System In Coronary
Completed
- Coronary Stenosis
- +3 more
- EluNIR Ridaforolimus Eluting Coronary Stent System
-
Be'er Sheva, Israel
- +8 more
Apr 5, 2022
Myocardial Ischemia After Coronary Sinus Reduction Stent
Not yet recruiting
- Angina Pectoris
- Coronary sinus reduction stent
- (no location specified)
Sep 5, 2023
Coronary Artery Disease Trial in Qingdao (Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System)
Active, not recruiting
- Coronary Artery Disease
- Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System
-
Qingdao, Shandong, ChinaQiLu Hospital of ShanDong University
Jul 8, 2022
Coronary Artery Disease Trial in Worldwide (Resolute Integrity Zotarolimus eluting stent, Xience Xpedition everolimus eluting
Completed
- Coronary Artery Disease
- Resolute Integrity Zotarolimus eluting stent
- +3 more
-
Atlanta, Georgia
- +9 more
Aug 16, 2022